Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1,191	1,018	977.89	942.26	833.35	800.35
Revenue Growth (YoY)	19.12%	4.07%	3.78%	13.07%	4.12%	-3.34%
Cost of Revenue	806.46	704.07	679.65	656.55	561.97	543.19
Gross Profit	384.23	313.61	298.24	285.72	271.38	257.16
Selling, General & Admin	232.9	217.89	192.06	183.53	193.82	189.62
Research & Development	29.19	29.19	24.4	20.83	-	-
Other Operating Expenses	4.2	4.2	6.89	-	-	-
Operating Expenses	269.28	254.27	226.39	207.34	196.51	189.62
Operating Income	114.94	59.34	71.85	78.38	74.87	67.54
Interest Expense	-32.23	-23.01	-18.68	-12.69	-12.7	-14.61
Interest & Investment Income	3.46	4.47	3.36	0.82	0.84	1.76
Currency Exchange Gain (Loss)	-13.88	-23.86	-2.46	5.22	4.48	-0.83
EBT Excluding Unusual Items	72.29	16.94	54.07	71.72	67.49	53.86
Merger & Restructuring Charges	-27.41	-6.93	-	-0.6	-	-1.17
Gain (Loss) on Sale of Investments	-	-	-	1.2	-	-
Other Unusual Items	-1.96	-	-	-	-1.02	2.82
Pretax Income	50.55	10.92	54.07	72.33	66.47	55.51
Income Tax Expense	18.76	8.5	21.47	23.15	12.08	21.96
Net Income	31.79	2.42	32.61	49.18	54.39	33.55
Net Income to Common	31.79	2.42	32.61	49.18	54.39	33.55
Net Income Growth	141.54%	-92.59%	-33.69%	-9.58%	62.09%	-38.68%
Shares Outstanding (Basic)	41	41	41	41	40	40
Shares Outstanding (Diluted)	41	41	41	41	41	41
Shares Change (YoY)	0.33%	0.05%	-	-	-	-0.05%
EPS (Basic)	0.78	0.06	0.81	1.21	1.34	0.83
EPS (Diluted)	0.78	0.06	0.81	1.21	1.34	0.83
EPS Growth	140.17%	-92.59%	-33.47%	-9.70%	61.57%	-38.56%
Free Cash Flow	49.06	46.36	-38.48	-5.4	18.99	25.3
Free Cash Flow Per Share	1.21	1.14	-0.95	-0.13	0.47	0.63
Dividend Per Share	0.480	0.480	0.480	0.480	0.480	0.480
Dividend Growth	-	-	-	-	-	4.35%
Gross Margin	32.27%	30.82%	30.50%	30.32%	32.56%	32.13%
Operating Margin	9.65%	5.83%	7.35%	8.32%	8.98%	8.44%
Profit Margin	2.67%	0.24%	3.33%	5.22%	6.53%	4.19%
Free Cash Flow Margin	4.12%	4.55%	-3.94%	-0.57%	2.28%	3.16%
EBITDA	155.9	94.08	104.4	110.04	105.5	98.84
EBITDA Margin	13.09%	9.25%	10.68%	11.68%	12.66%	12.35%
D&A For EBITDA	40.96	34.74	32.56	31.66	30.63	31.3
EBIT	114.94	59.34	71.85	78.38	74.87	67.54
EBIT Margin	9.65%	5.83%	7.35%	8.32%	8.98%	8.44%
Effective Tax Rate	37.11%	77.87%	39.70%	32.01%	18.18%	39.56%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q